首页> 外文期刊>Journal of Hainan Medical University >Value of arterial blood lactate and early lactate clearance in evaluating the prognosis in patients with COPD merged with respiratory failure
【24h】

Value of arterial blood lactate and early lactate clearance in evaluating the prognosis in patients with COPD merged with respiratory failure

机译:动脉血乳酸和乳酸早期清除在评估COPD合并呼吸衰竭患者的预后中的价值

获取原文
       

摘要

Objective: To explore the value of arterial blood lactate and early lactate clearance inevaluating the prognosis in patients with COPD merged with respiratory failure. Methods:A total of 78 patients with COPD merged with respiratory failure were included in the study.The arterial blood lactate level 1 d before treatment and 6 h after treatment was detected.The early lactate clearance was evaluated. The patients were divided into the severe elevationgroup, mild elevation group, and normal control group according to the blood lactate level.APACHE Ⅱ score, 28 d death rate, and other clinical related indicators in the three groupswere compared. According to the early lactate clearance, the patients were divided intothe high lactate clearance group and low lactate clearance group. The arterial blood lactatelevel, APACHE Ⅱ score, death rate, and arterial blood gas indicators in the two groupswere compared. The multiple-factor analysis of prognosis was performed. Results: With theincreasing of blood lactate concentration before treatment, APACHE Ⅱ score, mechanicalventilation time, ventilation rate, hospitalization time, and death rate were gradually elevated,and the comparison among the three groups was not statistically significant. When comparedwith before treatment, the arterial blood lactate level, APACHE Ⅱ score, and PaCO2 in thehigh lactate clearance group were significantly reduced, but PaO2 and pH were significantlyelevated, while PaO2 in the low lactate clearance group was significantly elevated. The deathrate in the high lactate clearance group was significantly lower than that in the low lactateclearance group. The early lactate clearance was a factor in protecting the prognosis in patientswith COPD merged with respiratory failure. Conclusions: The arterial blood lactate level andearly lactate clearance can affect the prognosis in patients with COPD merged with respiratoryfailure. Dynamic monitoring of early blood lactate level can better evaluate the disease severitydegree and prognosis.
机译:目的:探讨动脉血乳酸和早期乳酸清除对COPD合并呼吸衰竭患者预后的价值。方法:共纳入78例COPD合并呼吸衰竭的患者,观察治疗前1 d和治疗6 h的动脉血乳酸水平,评估早期乳酸清除率。根据血乳酸水平将患者分为重度升高组,轻度升高组和正常对照组。比较三组患者的APACHEⅡ评分,28 d死亡率和其他临床相关指标。根据早期乳酸清除率,将患者分为高乳酸清除率组和低乳酸清除率组。比较两组的动脉血乳酸水平,APACHEⅡ评分,死亡率和动脉血气指标。进行预后的多因素分析。结果:随着治疗前血乳酸浓度的升高,APACHEⅡ评分,机械通气时间,通气率,住院时间,死亡率均逐渐升高,三组间比较无统计学意义。高乳酸清除率组与治疗前相比,动脉血乳酸水平,APACHEⅡ评分和PaCO2明显降低,而高乳酸清除率组PaO2和pH明显升高,而PaO2则明显升高。高乳酸清除率组的死亡率显着低于低乳酸清除率组。早期乳酸清除是保护COPD合并呼吸衰竭患者预后的一个因素。结论:动脉血乳酸水平和早期乳酸清除率可影响COPD合并呼吸衰竭的患者的预后。动态监测早期血乳酸水平可以更好地评估疾病的严重程度和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号